DrRocker57
3 days ago
Avid stepping up their game now that they are in private hands.
TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at www.avidbio.com, combines Avidβs elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.
The reimagined Avid website captures the companyβs elevated brand through the tagline, βDiscover the Avid effect.™β, helping educate visitors on the differentiation that positions the company as one of the industryβs leading, most trusted biologics CDMOs. It offers a completely revamped customer experience highlighted by user-friendly navigation, improved accessibility, video interaction, and educational resources.
βAs a company that places the highest priority on delivering exceptional quality service and exceeding the expectations of our customers, we felt compelled to bring that same ethos to our online presence,β said Nick Green, president and chief executive officer of Avid. βWe take great pride in unveiling our new company website as a showcase to the Avid brand, capturing the spirit of our team, our unrivaled expertise, world-class facilities, and personalized process. For those that already have a relationship with Avid, we expect the new site will align with their experience. For those just getting to know us, we hope it will serve as a trusted and valuable resource for exploration, education, and engagement.β
bfiest
6 days ago
Bavi being revived -- Very Predictable. Yes this was all planned. Just as a reminder.
Royalty rate:
9,00 %; 11,00 %; 13,00 %; 14,00 %; 16,00 %
Base:
Net sale
Other payments:
Licensee shall pay to licensor the following payments: $3,000,000; $3,000,000; $2,000,000; Licensee shall pay to licensor the following milestone payments: $1,000,000; $2,000,000; $8,000,000; $5,000,000; $4,000,000; $30,000,000; $25,000,000;no $15,000,000; $5,000,000; In the event of licensee's sublicensing, licensee shall pay to licensor the following sublicensing revenue share percentage payments as follows: an amount equal to 0,30 multiplied by aggregate Phase II sublicensing revenue received by licensee and its affiliates (from or in all countries and territories) during the applicable quarter, or an amount equal to 0,15 multiplied by aggregate Phase III sublicensing revenue received by licensee and its affiliates (from or in all countries and territories) during the applicable quarter.
Compensation details:
Licensee shall pay to licensor royalty fees as follows: an amount equal to 9% of aggregate net sales (in all countries and territories) of up to $100,000,000 of each product; An amount equal to 11% of aggregate net sales (in all countries and territories) from $100,000,001 to $200,000,000 of each product; An amount equal to 13% of aggregate net sales (in all countries and territories) from $200,000,001 to $500,000,000 of each product; An amount equal to 14% of aggregate net sales (in all countries and territories) from $500,000,001 to $1,000,000,000 for each product; An amount equal to 16% of aggregate net sales (in all countries and territories) equal to or greater than $1,000,000,001 for each product.
Also the manufacturing rights were Avid's!
4OurRetirement
7 days ago
Per Google, The Bavituximab Patent Has Been Revised...
Google link:
https://patents.google.com/patent/US20180289771A1/en
Imho, Someone Manipulated Sale Of $CDMO
And Stole It And This Patent From StockHOLDers!
Patent Expiration Now Revised To:
"Status-Active, 2038-05-30 Adjusted expiration"
Per Google, The Current Assignees:
"Oncxerna Therapeutics Inc Avid Bioservices Inc"
And We Know Oncxerna Became Oncologie
And Is Now Defunct, Which Means
Avid's New Owners Retain 100% Of Patent.
Also, USPTO.gov Shows NO RESULTS FOUND
When Searching For Patent US20180289771A1,
Avid Bioservices, OR Bavituximab.
So, The Apparent Theft Seems Complete...
(All in my humble opinion).
Glta Retail Stock Investors In Future Investments!
Preciouslife1
1 week ago
SADLY OR VERY SADLY I'M OUT
AT $12.50 YESTERDAY WAITED MOSTLY FOR MAX RIPPOFF PRICE?? It's been real, and an honor pleasure to moderate his board for several years, and being in contact with so many other long-standing shareholders since 1997 here!! Sadly, many passed away before this ever got to fruition of Bavutuxiimab and PPHM Having and showing great success!
Now, on hindsight, the build outs were a joke, Management and the accountants were and are just Disreputable, immoral, untruthful and bothering on criminal!
The only time I sold in the last 28 years, was when The share price was over $34 a share praise God!
Now settling for 1250 a share is not the end of the world, but it is a slap in the face and I hit to the pocket!
Current management has dishonored and be Smurfs the name of Dr. Philip Thorpe imho!!
This little company was destined to become a gem in the biotech world; Until she or evil and underhanded entities and people sabotage this company and the trials, forcing the sale of Bavi and making the sub secretary of AVID THE FACE AND EQUITY OF THE COMPANY KNOWN AS CDMO!
I'm sure this board will go away shortly so I won't even bother resigning as moderator and I will still check in because I have many friends here! Blessings to all, and I hope you red deploy the assets for good use and good profits in the future to help circumvent the Al Capone and Bonnie and Clyde Management of CDMO!
north40000
2 weeks ago
Avid Bioservices was incorporated in Delaware in 1996 via Techniclone and Peregrine. Avid conducts its business activities in California. A suit to recover our lost use of Capital due to managements' and auditor's gross (may be deliberate)negligence in 1) failure to timely check boxes on forms and 2) managing corporate finances in a fiduciary manner may be brought in Wilmington, Delaware or San Jose/San Diego, California, IMO. A graph of Avid share price illustrates the facts relating to our lost use of capital date wise, before and after expansion was started/completed. We know the financing facts--originally at low interest rates and subsequently at high interest rates. The party(John Doe) that caused any management "mistake" in 1) and 2) above would be included as a defendant in the complaint, as would the 2 funds that have negotiated/completed the buyout/merger transaction. See California v. Texas, 141 S.Ct. 2104, 2113(2021) and TransUnion, LLC v. Ramirez, 141 S.Ct. 2190, 2203-2204(2021). See also FRCP 23.1 and 18f-4 regarding 4 year timeliness, bond requirements, and shareholders who have rights to bring shareholder derivative suits. A demand letter to Avid management and BOD looks futile, hence unnecessary.
Spouse and I are contemplating a shareholder derivative suit as outlined above. Is anyone here interested? A $50k bond in California(?) is a substantial cost that could be split. I have contacted no institutional shareholders to determine their interest, nor have I been able to talk with attorneys I know to ascertain their interest.